Oral Genome, founded with a mission to revolutionize dental health and wellness, focuses on early detection and prevention of oral health issues through advanced biotechnological solutions. The company offers a patent-pending salivary test that leverages adaptive learning to identify potential health conditions before they manifest, providing personalized insights for dental providers and patients. Their market focus is on integrating cutting-edge technology into routine dental care to enhance preventative measures and overall oral health.

Notable figures associated with Oral Genome include leading experts in dental biotechnology and health innovation. The company has garnered attention from prominent investors in the health tech sector, supporting its groundbreaking approach to oral care. Key achievements include the development and pending patent of their saliva-based diagnostic test, which has the potential to transform preventive dental practices. Oral Genome's impact lies in its ability to offer early detection solutions, ultimately aiming to improve long-term health outcomes for patients.